Recruiting Idiopathic Thrombocytopenic Purpura Studies in Westbury
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
The main purpose of this study is to look at the effect (efficacy) and safety of efgartigimod IV in participants with primary immune thrombocytopenia (ITP). After an up to 2 weeks screening period, el...
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
The purpose of the phase 1 part of this study is to evaluate how well pirtobrutinib is tolerated and what side effects may occur. The phase 2 part of the study will further investigate efficacy and sa...
About Idiopathic Thrombocytopenic Purpura Clinical Trials in Westbury
Immune thrombocytopenia (ITP) is an autoimmune condition where the immune system destroys platelets, leading to easy bruising and bleeding. It can occur in children (often self-limiting) or adults (often chronic). Treatment includes corticosteroids, thrombopoietin receptor agonists, and rituximab.
There are currently 2 idiopathic thrombocytopenic purpura clinical trials recruiting participants in Westbury, NEW%20YORK. These studies are seeking a combined 121 participants. Research is being sponsored by argenx, Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Idiopathic Thrombocytopenic Purpura Clinical Trials in Westbury — FAQ
Are there idiopathic thrombocytopenic purpura clinical trials in Westbury?
Yes, there are 2 idiopathic thrombocytopenic purpura clinical trials currently recruiting in Westbury, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Westbury?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Westbury research site will contact you about next steps.
Are clinical trials in Westbury free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Westbury studies also compensate for your time and travel.
What idiopathic thrombocytopenic purpura treatments are being tested?
The 2 active trials in Westbury are testing new therapies including novel drugs, biologics, and treatment approaches for idiopathic thrombocytopenic purpura.
Data updated March 2, 2026 from ClinicalTrials.gov